Differential effect of interferon-alpha treatment on AEA and 2-AG levels
Open Access
- 26 August 2020
- journal article
- research article
- Published by Elsevier BV in Brain, Behavior, and Immunity
- Vol. 90, 248-258
- https://doi.org/10.1016/j.bbi.2020.08.024
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health Research
- Medical Research Council
This publication has 52 references indexed in Scilit:
- Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: relationship to early cognitive dysfunction and late depressionProgress in Neurobiology, 2012
- The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cellsBrain, Behavior, and Immunity, 2011
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 ReceptorsPLOS ONE, 2010
- Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stressPsychoneuroendocrinology, 2009
- Endocannabinoids and immune regulationPharmacological Research, 2009
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-AnalysisPsychosomatic Medicine, 2009
- Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T CellsMolecular Pharmacology, 2008
- Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary ReportPharmacopsychiatry, 2008
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964